The use of dexamethasone early in the treatment of children with acute lymphoblastic leukemia, the most common type of childhood cancer, may help reduce the risk of relapse according to study results being presented in a press conference on Saturday, Dec. 6, at 2 p.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, Calif.